Post-transplant conversion from cyclospo
โ
F. Sutherland; E. Burgess; J. Klassen; S. Buckle; L. C. Paul
๐
Article
๐
1993
๐
Springer
๐
English
โ 420 KB
The benefits of long-term cyclosporin (CyA) therapy are not yet established and must be weighed against its toxicity. We studied cardiovascular risk factors in 25 patients who received a kidney transplant between 1985 and 1989 and in whom CyA was discontinued. The protocol for discontinuing CyA invo